Subscribe
19 November 2024NewsAmericasLiz Hockley

Kathi Vidal to rejoin previous firm as partner following USPTO departure

Vidal to return to Silicon Valley litigation department and advise on AI issues | Firm is ‘thrilled to welcome Kathi back’ and looking forward to benefitting from her leadership expertise.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Kathi Vidal to leave USPTO ahead of incoming Trump administration
14 November 2024   Vidal announced she will return to private sector after December departure | USPTO director told colleagues they had “transformed” the agency during her time there.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Americas
Kathi Vidal to leave USPTO ahead of incoming Trump administration
14 November 2024   Vidal announced she will return to private sector after December departure | USPTO director told colleagues they had “transformed” the agency during her time there.

More on this story

Americas
Kathi Vidal to leave USPTO ahead of incoming Trump administration
14 November 2024   Vidal announced she will return to private sector after December departure | USPTO director told colleagues they had “transformed” the agency during her time there.

More features

UPC bans Meril Life Sciences from selling infringing heart valve
GSK triumphs in EPO appeal, revoking Pfizer patent
‘We took Ravgen head-on’: How we won zero-damages and others didn't
Kathi Vidal to leave USPTO ahead of incoming Trump administration
Herbert Smith Freehills and Kramer Levin in $2bn merger talks
Teva fights for re-listing of inhaler patents at US appeals court
CRISPR patents revoked following Nobel Prize winners’ withdrawal
White & Case hires experienced litigator from A&O Shearman